The Latin America, Middle East and Africa Actinic Keratosis Treatment Market would witness market growth of 6.5% CAGR during the forecast period (2022-2028).
Due to factors including the higher occurrence of actinic keratosis and the widespread availability of generic medications for the treatment of the condition, the market is expected to have growth prospects. Additionally, growing public awareness of actinic keratosis and several strategic moves made by market participants are driving the market.
The extensive use of actinic keratosis drugs has been prompted by a greater understanding of the diagnostic methods and therapeutic approaches for this condition. Over the coming years, the market penetration of field-directed medications such as 5-fluorouracil, Ingenol mebutate, diclofenac, and Imiquimod is expected to increase.
The results of photodynamic therapy were found to be more favorable than those of cryotherapy in regard to appearance. Actinic keratosis treatments' widespread accessibility and availability are anticipated to significantly boost this growth of the market.
Acral lentiginous melanoma (ALM) is a significant melanoma subtype, in which cells become cancerous, in Latin America. According to several case studies and case-control studies, trauma is a potential risk for melanomas that develop at acral sites, and more particularly for ALM. A higher incidence of foot and hand skin cancers and/or ALM has also been linked to harmless nevi on the toes or soles. The majority of Colombians have different traits with a substantially greater percentage of acral melanomas, extremely final stages at diagnosis, and subpar prognosis.
The Brazil market dominated the LAMEA Actinic Keratosis Treatment Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $132.4 Million by 2028.The Argentina market is experiencing a CAGR of 7% during (2022 - 2028). Additionally, The UAE market would exhibit a CAGR of 6.2% during (2022 - 2028).
Based on Drug Class, the market is segmented into Nucleoside Metabolic Inhibitor, NSAIDs, Immune Response Modifiers, Photoenhancers and Others. Based on Therapy, the market is segmented into Surgery, Topical and Photodynamic Therapy. Based on End-use, the market is segmented into Hospitals, Private Clinics, Homecare and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
Free Valuable Insights: The Global Actinic Keratosis Treatment Market is Predict to reach $8 Billion by 2028, at a CAGR of 4.4%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Almirall, S.A, LEO Pharma A/S, Biofrontera AG, Sun Pharmaceuticals Industries Ltd., 3M Company, Bausch Health Companies, Inc., Novartis AG, Viatris, Inc., and Galderma S.A.
Scope of the Study
Market Segments Covered in the Report:
By Drug Class
- Nucleoside Metabolic Inhibitor
- NSAIDs
- Immune Response Modifiers
- Photoenhancers
- Others
By Therapy
- Surgery
- Topical
- Photodynamic Therapy
By End-use
- Hospitals
- Private Clinics
- Homecare
- Others
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- Almirall, S.A
- LEO Pharma A/S
- Biofrontera AG
- Sun Pharmaceuticals Industries Ltd.
- 3M Company
- Bausch Health Companies, Inc.
- Novartis AG
- Viatris, Inc.
- Galderma S.A.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Actinic Keratosis Treatment Market, by Drug Class
1.4.2 LAMEA Actinic Keratosis Treatment Market, by Therapy
1.4.3 LAMEA Actinic Keratosis Treatment Market, by End-use
1.4.4 LAMEA Actinic Keratosis Treatment Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. LAMEA Actinic Keratosis Treatment Market by Drug Class
3.1 LAMEA Nucleoside Metabolic Inhibitor Market by Country
3.2 LAMEA NSAIDs Market by Country
3.3 LAMEA Immune Response Modifiers Market by Country
3.4 LAMEA Photoenhancers Market by Country
3.5 LAMEA Others Market by Country
Chapter 4. LAMEA Actinic Keratosis Treatment Market by Therapy
4.1 LAMEA Surgery Market by Country
4.2 LAMEA Topical Market by Country
4.3 LAMEA Photodynamic Therapy Market by Country
Chapter 5. LAMEA Actinic Keratosis Treatment Market by End-use
5.1 LAMEA Hospitals Market by Country
5.2 LAMEA Private Clinics Market by Country
5.3 LAMEA Homecare Market by Country
5.4 LAMEA Others Market by Country
Chapter 6. LAMEA Actinic Keratosis Treatment Market by Country
6.1 Brazil Actinic Keratosis Treatment Market
6.1.1 Brazil Actinic Keratosis Treatment Market by Drug Class
6.1.2 Brazil Actinic Keratosis Treatment Market by Therapy
6.1.3 Brazil Actinic Keratosis Treatment Market by End-use
6.2 Argentina Actinic Keratosis Treatment Market
6.2.1 Argentina Actinic Keratosis Treatment Market by Drug Class
6.2.2 Argentina Actinic Keratosis Treatment Market by Therapy
6.2.3 Argentina Actinic Keratosis Treatment Market by End-use
6.3 UAE Actinic Keratosis Treatment Market
6.3.1 UAE Actinic Keratosis Treatment Market by Drug Class
6.3.2 UAE Actinic Keratosis Treatment Market by Therapy
6.3.3 UAE Actinic Keratosis Treatment Market by End-use
6.4 Saudi Arabia Actinic Keratosis Treatment Market
6.4.1 Saudi Arabia Actinic Keratosis Treatment Market by Drug Class
6.4.2 Saudi Arabia Actinic Keratosis Treatment Market by Therapy
6.4.3 Saudi Arabia Actinic Keratosis Treatment Market by End-use
6.5 South Africa Actinic Keratosis Treatment Market
6.5.1 South Africa Actinic Keratosis Treatment Market by Drug Class
6.5.2 South Africa Actinic Keratosis Treatment Market by Therapy
6.5.3 South Africa Actinic Keratosis Treatment Market by End-use
6.6 Nigeria Actinic Keratosis Treatment Market
6.6.1 Nigeria Actinic Keratosis Treatment Market by Drug Class
6.6.2 Nigeria Actinic Keratosis Treatment Market by Therapy
6.6.3 Nigeria Actinic Keratosis Treatment Market by End-use
6.7 Rest of LAMEA Actinic Keratosis Treatment Market
6.7.1 Rest of LAMEA Actinic Keratosis Treatment Market by Drug Class
6.7.2 Rest of LAMEA Actinic Keratosis Treatment Market by Therapy
6.7.3 Rest of LAMEA Actinic Keratosis Treatment Market by End-use
Chapter 7. Company Profiles
7.1 Almirall, S.A
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expenses
7.1.5 Recent strategies and developments:
7.1.5.1 Partnerships, Collaborations, and Agreements:
7.1.5.2 Product Launches and Product Expansions:
7.2 LEO Pharma A/S
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Regional Analysis
7.2.4 Research & Development Expense
7.2.5 Recent strategies and developments:
7.2.5.1 Partnerships, Collaborations, and Agreements:
7.3 Biofrontera AG
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Research & Development Expenses
7.4 Sun Pharmaceuticals Industries Ltd.
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Regional Analysis
7.4.4 Research & Development Expenses
7.5 3M Company
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expense
7.5.5 SWOT Analysis
7.6 Bausch Health Companies, Inc.
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expense
7.7 Novartis AG
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expense
7.8 Viatris, Inc.
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental and Regional Analysis
7.8.4 Research & Development Expense
7.9 Galderma S.A.
7.9.1 Company Overview
TABLE 1 LAMEA Actinic Keratosis Treatment Market, 2018 - 2021, USD Million
TABLE 2 LAMEA Actinic Keratosis Treatment Market, 2022 - 2028, USD Million
TABLE 3 LAMEA Actinic Keratosis Treatment Market by Drug Class, 2018 - 2021, USD Million
TABLE 4 LAMEA Actinic Keratosis Treatment Market by Drug Class, 2022 - 2028, USD Million
TABLE 5 LAMEA Nucleoside Metabolic Inhibitor Market by Country, 2018 - 2021, USD Million
TABLE 6 LAMEA Nucleoside Metabolic Inhibitor Market by Country, 2022 - 2028, USD Million
TABLE 7 LAMEA NSAIDs Market by Country, 2018 - 2021, USD Million
TABLE 8 LAMEA NSAIDs Market by Country, 2022 - 2028, USD Million
TABLE 9 LAMEA Immune Response Modifiers Market by Country, 2018 - 2021, USD Million
TABLE 10 LAMEA Immune Response Modifiers Market by Country, 2022 - 2028, USD Million
TABLE 11 LAMEA Photoenhancers Market by Country, 2018 - 2021, USD Million
TABLE 12 LAMEA Photoenhancers Market by Country, 2022 - 2028, USD Million
TABLE 13 LAMEA Others Market by Country, 2018 - 2021, USD Million
TABLE 14 LAMEA Others Market by Country, 2022 - 2028, USD Million
TABLE 15 LAMEA Actinic Keratosis Treatment Market by Therapy, 2018 - 2021, USD Million
TABLE 16 LAMEA Actinic Keratosis Treatment Market by Therapy, 2022 - 2028, USD Million
TABLE 17 LAMEA Surgery Market by Country, 2018 - 2021, USD Million
TABLE 18 LAMEA Surgery Market by Country, 2022 - 2028, USD Million
TABLE 19 LAMEA Topical Market by Country, 2018 - 2021, USD Million
TABLE 20 LAMEA Topical Market by Country, 2022 - 2028, USD Million
TABLE 21 LAMEA Photodynamic Therapy Market by Country, 2018 - 2021, USD Million
TABLE 22 LAMEA Photodynamic Therapy Market by Country, 2022 - 2028, USD Million
TABLE 23 LAMEA Actinic Keratosis Treatment Market by End-use, 2018 - 2021, USD Million
TABLE 24 LAMEA Actinic Keratosis Treatment Market by End-use, 2022 - 2028, USD Million
TABLE 25 LAMEA Hospitals Market by Country, 2018 - 2021, USD Million
TABLE 26 LAMEA Hospitals Market by Country, 2022 - 2028, USD Million
TABLE 27 LAMEA Private Clinics Market by Country, 2018 - 2021, USD Million
TABLE 28 LAMEA Private Clinics Market by Country, 2022 - 2028, USD Million
TABLE 29 LAMEA Homecare Market by Country, 2018 - 2021, USD Million
TABLE 30 LAMEA Homecare Market by Country, 2022 - 2028, USD Million
TABLE 31 LAMEA Others Market by Country, 2018 - 2021, USD Million
TABLE 32 LAMEA Others Market by Country, 2022 - 2028, USD Million
TABLE 33 LAMEA Actinic Keratosis Treatment Market by Country, 2018 - 2021, USD Million
TABLE 34 LAMEA Actinic Keratosis Treatment Market by Country, 2022 - 2028, USD Million
TABLE 35 Brazil Actinic Keratosis Treatment Market, 2018 - 2021, USD Million
TABLE 36 Brazil Actinic Keratosis Treatment Market, 2022 - 2028, USD Million
TABLE 37 Brazil Actinic Keratosis Treatment Market by Drug Class, 2018 - 2021, USD Million
TABLE 38 Brazil Actinic Keratosis Treatment Market by Drug Class, 2022 - 2028, USD Million
TABLE 39 Brazil Actinic Keratosis Treatment Market by Therapy, 2018 - 2021, USD Million
TABLE 40 Brazil Actinic Keratosis Treatment Market by Therapy, 2022 - 2028, USD Million
TABLE 41 Brazil Actinic Keratosis Treatment Market by End-use, 2018 - 2021, USD Million
TABLE 42 Brazil Actinic Keratosis Treatment Market by End-use, 2022 - 2028, USD Million
TABLE 43 Argentina Actinic Keratosis Treatment Market, 2018 - 2021, USD Million
TABLE 44 Argentina Actinic Keratosis Treatment Market, 2022 - 2028, USD Million
TABLE 45 Argentina Actinic Keratosis Treatment Market by Drug Class, 2018 - 2021, USD Million
TABLE 46 Argentina Actinic Keratosis Treatment Market by Drug Class, 2022 - 2028, USD Million
TABLE 47 Argentina Actinic Keratosis Treatment Market by Therapy, 2018 - 2021, USD Million
TABLE 48 Argentina Actinic Keratosis Treatment Market by Therapy, 2022 - 2028, USD Million
TABLE 49 Argentina Actinic Keratosis Treatment Market by End-use, 2018 - 2021, USD Million
TABLE 50 Argentina Actinic Keratosis Treatment Market by End-use, 2022 - 2028, USD Million
TABLE 51 UAE Actinic Keratosis Treatment Market, 2018 - 2021, USD Million
TABLE 52 UAE Actinic Keratosis Treatment Market, 2022 - 2028, USD Million
TABLE 53 UAE Actinic Keratosis Treatment Market by Drug Class, 2018 - 2021, USD Million
TABLE 54 UAE Actinic Keratosis Treatment Market by Drug Class, 2022 - 2028, USD Million
TABLE 55 UAE Actinic Keratosis Treatment Market by Therapy, 2018 - 2021, USD Million
TABLE 56 UAE Actinic Keratosis Treatment Market by Therapy, 2022 - 2028, USD Million
TABLE 57 UAE Actinic Keratosis Treatment Market by End-use, 2018 - 2021, USD Million
TABLE 58 UAE Actinic Keratosis Treatment Market by End-use, 2022 - 2028, USD Million
TABLE 59 Saudi Arabia Actinic Keratosis Treatment Market, 2018 - 2021, USD Million
TABLE 60 Saudi Arabia Actinic Keratosis Treatment Market, 2022 - 2028, USD Million
TABLE 61 Saudi Arabia Actinic Keratosis Treatment Market by Drug Class, 2018 - 2021, USD Million
TABLE 62 Saudi Arabia Actinic Keratosis Treatment Market by Drug Class, 2022 - 2028, USD Million
TABLE 63 Saudi Arabia Actinic Keratosis Treatment Market by Therapy, 2018 - 2021, USD Million
TABLE 64 Saudi Arabia Actinic Keratosis Treatment Market by Therapy, 2022 - 2028, USD Million
TABLE 65 Saudi Arabia Actinic Keratosis Treatment Market by End-use, 2018 - 2021, USD Million
TABLE 66 Saudi Arabia Actinic Keratosis Treatment Market by End-use, 2022 - 2028, USD Million
TABLE 67 South Africa Actinic Keratosis Treatment Market, 2018 - 2021, USD Million
TABLE 68 South Africa Actinic Keratosis Treatment Market, 2022 - 2028, USD Million
TABLE 69 South Africa Actinic Keratosis Treatment Market by Drug Class, 2018 - 2021, USD Million
TABLE 70 South Africa Actinic Keratosis Treatment Market by Drug Class, 2022 - 2028, USD Million
TABLE 71 South Africa Actinic Keratosis Treatment Market by Therapy, 2018 - 2021, USD Million
TABLE 72 South Africa Actinic Keratosis Treatment Market by Therapy, 2022 - 2028, USD Million
TABLE 73 South Africa Actinic Keratosis Treatment Market by End-use, 2018 - 2021, USD Million
TABLE 74 South Africa Actinic Keratosis Treatment Market by End-use, 2022 - 2028, USD Million
TABLE 75 Nigeria Actinic Keratosis Treatment Market, 2018 - 2021, USD Million
TABLE 76 Nigeria Actinic Keratosis Treatment Market, 2022 - 2028, USD Million
TABLE 77 Nigeria Actinic Keratosis Treatment Market by Drug Class, 2018 - 2021, USD Million
TABLE 78 Nigeria Actinic Keratosis Treatment Market by Drug Class, 2022 - 2028, USD Million
TABLE 79 Nigeria Actinic Keratosis Treatment Market by Therapy, 2018 - 2021, USD Million
TABLE 80 Nigeria Actinic Keratosis Treatment Market by Therapy, 2022 - 2028, USD Million
TABLE 81 Nigeria Actinic Keratosis Treatment Market by End-use, 2018 - 2021, USD Million
TABLE 82 Nigeria Actinic Keratosis Treatment Market by End-use, 2022 - 2028, USD Million
TABLE 83 Rest of LAMEA Actinic Keratosis Treatment Market, 2018 - 2021, USD Million
TABLE 84 Rest of LAMEA Actinic Keratosis Treatment Market, 2022 - 2028, USD Million
TABLE 85 Rest of LAMEA Actinic Keratosis Treatment Market by Drug Class, 2018 - 2021, USD Million
TABLE 86 Rest of LAMEA Actinic Keratosis Treatment Market by Drug Class, 2022 - 2028, USD Million
TABLE 87 Rest of LAMEA Actinic Keratosis Treatment Market by Therapy, 2018 - 2021, USD Million
TABLE 88 Rest of LAMEA Actinic Keratosis Treatment Market by Therapy, 2022 - 2028, USD Million
TABLE 89 Rest of LAMEA Actinic Keratosis Treatment Market by End-use, 2018 - 2021, USD Million
TABLE 90 Rest of LAMEA Actinic Keratosis Treatment Market by End-use, 2022 - 2028, USD Million
TABLE 91 Key Information – Almirall, S.A
TABLE 92 key information – LEO Pharma A/S
TABLE 93 Key Information – Biofrontera AG
TABLE 94 Key Information – Sun Pharmaceuticals Industries Ltd.
TABLE 95 Key Information – 3M Company
TABLE 96 key information – Bausch Health Companies, Inc.
TABLE 97 Key Information – Novartis AG
TABLE 98 key information – Viatris, Inc.
TABLE 99 Key Information – Galderma S.A.
List of Figures
FIG 1 Methodology for the research
FIG 2 Recent strategies and developments: Almirall, S.A
FIG 3 SWOT Analysis: 3M Company